Professional Documents
Culture Documents
JHMBF 01682 Sup 0001
JHMBF 01682 Sup 0001
Things We Do
for No Reason™
Routinely Prescribing Transfusion Premedication To Prevent
Acute Transfusion Reactions
Based on Lim MY, Pagano MB, Metcalf RA. Routinely Prescribing Transfusion
Premedication To Prevent Acute Transfusion Reaction. J Hosp Med. 2020;15(11):684-686.
@JHospMedicine | #TWDFNR
Clinical Scenario
• 68-year-old woman is admitted for fatigue and shortness of breath
on exertion with a hemoglobin of 6.5 g/dL
• Past Medical History: Myelodysplastic syndrome
• Vital signs: Tachycardic with heart rate of 105
• Treatment: First red blood cell (RBC) transfusion
• Hospitalist orders premedication with acetaminophen and
diphenhydramine to prevent acute transfusion reaction
@JHospMedicine | #TWDFNR
Why You Might Think This is Necessary
• The most frequent complications of blood transfusion are
allergic transfusion reactions (ATRs) and febrile
nonhemolytic transfusion reactions (FNHTRs), with a
combined incidence of 1% – 4% per transfusion1
• Perhaps acetaminophen could blunt the febrile response in
FHNTRs
• ATRs, which are caused by recipient histamine release in
response to exposure to donor plasma proteins, could
theoretically be prevented by an antihistamine
@JHospMedicine | #TWDFNR
Why This Is Not Helpful
• Randomized controlled trials show premedication with acetaminophen and
an antihistamine does not reduce the risk of ATR and FNHTR2-4
Acetaminophen and
Rujkijyanont 147 with
RBC transfusion chlorpheniramine vs 6.90% 9.50% 0.565
(2018) thalassemia
placebo
@JHospMedicine | #TWDFNR
What You Should Do Instead
• Rather than pretreating the patient, consider modifying the blood product
selected for transfusion
• Prestorage leukoreduction of RBC and platelet components to remove
donor leukocytes reduces incidence of FNHTRs by approximately 50%5
• Plasma volume reduction to decrease coadministration of allergy-inducing
plasma proteins reduces incidence of platelet-associated ATRs by 50%6
• For patients with recurrent severe ATRs, blood banks can wash RBC and
platelet components, removing virtually all plasma proteins7
• Avoid unnecessary transfusions
@JHospMedicine | #TWDFNR
Recommendations
• Do not prescribe an antihistamine or acetaminophen prior to transfusion
• Reduce the risk of FNHTRs in all transfusion recipients with universal
prestorage leukoreduction
• For individuals with multiple recurrent ATRs to platelets, employ platelet
additive solution or platelet volume reduction to reduce the plasma
volume administered
• Reserve washing RBC and platelet components for patients with a history
of severe ATRs
• Make sure epinephrine is at the patient’s bedside
• Curb unnecessary blood transfusions to reduce avoidable transfusion
reactions
• Monitor patients undergoing transfusion closely
@JHospMedicine | #TWDFNR
Conclusions
• No indication for premedication with acetaminophen and/or
antihistamine in this case scenario
• Avoid unnecessary transfusion — if a transfusion does not
occur, then neither will a transfusion reaction
@JHospMedicine | #TWDFNR
References
Based on Lim MY, Pagano MB, Metcalf RA. Routinely Prescribing Transfusion Premedication To Prevent Acute
Transfusion Reaction. J Hosp Med. 2020;15(11):684-686.
1.Fung MK, Eder A, Spitalnik SL, Westhoff CM. American Association of Blood Banks Technical Manual. 19th Ed: Bethesda, Md: AABB; 2017.
2.Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled
trial. Am J Hematol. 2002;70(3):191-194.
3.A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo
for the prevention of transfusion reactions. Transfusion. 2008;48(11):2285-2291.
4.Efficacy of oral acetaminophen and intravenous chlorpheniramine maleate versus placebo to prevent red cell transfusion reactions in
children and adolescent with thalassemia: a prospective, randomized, double-blind controlled trial. Anemia. 2018;2018:9492303.
5.Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion. 2004;44(1):25-29.
6.Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy. Transfusion.
2019;59(4):1246-1251.
7.Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion. 2011;51(8):1676-1683.
@JHospMedicine | #TWDFNR
Citation
To cite this teaching tool:
@JHospMedicine | #TWDFNR
@JHospMedicine | #TWDFNR